Publisher correction: first-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer : the phase 3 TALAPRO-2 trial

Saved in:
Bibliographic Details
Main Authors: Fizazi, Karim (Author) , Azad, Arun A. (Author) , Matsubara, Nobuaki (Author) , Carles, Joan (Author) , Fay, Andre P. (Author) , Giorgi, Ugo de (Author) , Joung, Jae Young (Author) , Fong, Peter C. C. (Author) , Voog, Eric (Author) , Jones, Robert J. (Author) , Shore, Neal D. (Author) , Dunshee, Curtis (Author) , Zschäbitz, Stefanie (Author) , Oldenburg, Jan (Author) , Ye, Dingwei (Author) , Lin, Xun (Author) , Healy, Cynthia G. (Author) , Di Santo, Nicola (Author) , Laird, A. Douglas (Author) , Zohren, Fabian (Author) , Agarwal, Neeraj (Author)
Format: Article (Journal)
Language:English
Published: 31 January 2024
In: Nature medicine
Year: 2024, Volume: 30, Issue: 5, Pages: 1505
ISSN:1546-170X
DOI:10.1038/s41591-024-02835-9
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41591-024-02835-9
Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41591-024-02835-9
Get full text
Author Notes:Karim Fizazi, Arun A. Azad, Nobuaki Matsubara, Joan Carles, Andre P. Fay, Ugo De Giorgi, Jae Young Joung, Peter C.C. Fong, Eric Voog, Robert J. Jones, Neal D. Shore, Curtis Dunshee, Stefanie Zschäbitz, Jan Oldenburg, Dingwei Ye, Xun Lin, Cynthia G. Healy, Nicola Di Santo, A. Douglas Laird, Fabian Zohren & Neeraj Agarwal
Description
Item Description:Gesehen am 19.02.2024
Physical Description:Online Resource
ISSN:1546-170X
DOI:10.1038/s41591-024-02835-9